Papillomaviruses in the causation of human cancers - a brief historical account
- PMID: 19135222
- DOI: 10.1016/j.virol.2008.11.046
Papillomaviruses in the causation of human cancers - a brief historical account
Abstract
Approximately 35 years ago a role of human papillomaviruses (HPV) in cervical cancer has been postulated. Today it is well established that this very heterogeneous virus family harbours important human carcinogens, causing not only the vast majority of cervical, but also a substantial proportion of other anogenital and head and neck cancers. In addition, specific types have been linked to certain cutaneous cancers. In females, HPV infections on a global scale account for more than 50% of infection-linked cancers, in males for barely 5%. Vaccines against the high risk HPV types 16 and 18 represent the first preventive vaccines directly developed to protect against a major human cancer (cervical carcinoma). This review will cover some of the historical aspects of papillomavirus research; it tries briefly to analyze the present state of linking HPV to human cancers and will discuss some emerging developments.
Similar articles
-
[Papillomaviruses and genital cancer: the value of detection and eradication].Prog Urol. 1994 Aug-Sep;4(4):491-8. Prog Urol. 1994. PMID: 7920725 Review. French.
-
Human papillomaviruses in cervical cancer I. HPV-16 and 18 predominate in the Greek population.Anticancer Res. 1997 Jan-Feb;17(1A):117-20. Anticancer Res. 1997. PMID: 9066640
-
Human papillomavirus in head and neck cancer: molecular biology and clinicopathological correlations.Cancer Metastasis Rev. 2005 Jan;24(1):19-34. doi: 10.1007/s10555-005-5045-3. Cancer Metastasis Rev. 2005. PMID: 15785870 Review.
-
Annual disease burden due to human papillomavirus (HPV) 6 and 11 infections in Finland.Scand J Infect Dis Suppl. 2009;107:3-32. doi: 10.1080/00365540902887730. Scand J Infect Dis Suppl. 2009. PMID: 19408160 Review.
-
Papillomaviruses as targets for cancer gene therapy.Cancer Gene Ther. 1994 Sep;1(3):193-204. Cancer Gene Ther. 1994. PMID: 7621251 Review.
Cited by
-
A safe and potentiated multi-type HPV L2-E7 nanoparticle vaccine with combined prophylactic and therapeutic activity.NPJ Vaccines. 2024 Jun 26;9(1):119. doi: 10.1038/s41541-024-00914-z. NPJ Vaccines. 2024. PMID: 38926425 Free PMC article.
-
[Human papillomavirus in squamous cell cancer of the head and neck. A study at the Ulm Military Hospital, Germany].HNO. 2013 Jul;61(7):593-601. doi: 10.1007/s00106-013-2676-5. HNO. 2013. PMID: 23842698 German.
-
Retrospective analysis of HPV 16/18-related disease burden using archival clinical samples.J Cancer Res Clin Oncol. 2016 Nov;142(11):2367-73. doi: 10.1007/s00432-016-2227-z. Epub 2016 Aug 30. J Cancer Res Clin Oncol. 2016. PMID: 27573495
-
Human Papilloma Virus-Infected Cells.Subcell Biochem. 2023;106:213-226. doi: 10.1007/978-3-031-40086-5_8. Subcell Biochem. 2023. PMID: 38159229
-
cIAP-2 protein is upregulated by human papillomavirus in oropharyngeal cancers: role in radioresistance in vitro.Infect Agent Cancer. 2024 Sep 27;19(1):47. doi: 10.1186/s13027-024-00609-z. Infect Agent Cancer. 2024. PMID: 39334439 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical